GPT and fatty liver disease: AN1284 was able to decrease hepatocellular damage and hepatic steatosis, as manifested by a lower liver weight (Figure 6A), serum levels of ALT and ALP (Figures 6B,C), as well as hepatic triglyceride and cholesterol contents (Figures 6D,E).